Analyst Ranking
Bottom 3%
#4782 out of 4923 analysts
Average Return
-9.86%
Win Rate
34%34 out of 99
Risk vs Reward
Poor
Good

Peter Lawson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Immunogen IncIMGN
+214.57%$5.01$15.76
2022-11-15 -
2023-11-14
Strong Buy
Immunogen IncIMGN
+187.55%$5.46$15.70
2022-09-09 -
2023-09-08
Strong Buy
Immunomedics IncIMMU
+171.17%$32.40$87.86
2020-05-05 -
2020-10-22
Strong Buy
Fate Therapeutics IncFATE
+170.37%$30.75$83.14
2020-03-04 -
2021-03-04
Strong Buy
Syndax Pharmaceuticals IncSNDX
+100.18%$11.28$22.58
2020-03-04 -
2021-03-04
Strong Buy

Peter Lawson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Macrogenics IncMGNX
9Strong Buy$3.00+147.93%Maintains
2 months ago
Fate Therapeutics IncFATE
4Strong Buy$2.00+78.57%Maintains
2 months ago
Adaptimmune Therapeutics PLCADAP
3Strong Sell$0.46+91.67%Maintains
2 months ago
Karyopharm Therapeutics IncKPTI
3Strong Buy$10.00+132.02%Maintains
2 months ago
Iovance Biotherapeutics IncIOVA
6Strong Buy$4.00+132.56%Maintains
2 months ago
Xencor IncXNCR
2Strong Sell$6.00-23.66%Maintains
2 months ago
Kura Oncology IncKURA
1Strong Buy$11.00+90.64%Maintains
2 months ago
Arvinas IncARVN
8Strong Buy$16.00+117.39%Maintains
2 months ago
Bicycle Therapeutics PLCBCYC
2Strong Buy$15.00+115.83%Maintains
2 months ago
Springworks Therapeutics IncSWTX
4Hold$47.00+0.02%Downgrades
2 months ago
Arcus Biosciences IncRCUS
7Strong Buy$14.00+71.99%Maintains
2 months ago
Biomea Fusion IncBMEA
5Hold$3.00+66.67%Maintains
3 months ago
Tscan Therapeutics IncTCRX
2Strong Buy$3.00+106.90%Maintains
4 months ago
Geron CorpGERN
1Strong Buy$4.00+183.69%Maintains
4 months ago
Exelixis IncEXEL
5Hold$29.00-34.20%Maintains
5 months ago
Revolution Medicines IncRVMD
3Strong Buy$60.00+63.09%Maintains
9 months ago
Relay Therapeutics IncRLAY
5Strong Buy$17.00+391.33%Maintains
10 months ago
Syndax Pharmaceuticals IncSNDX
3Strong Buy$33.00+252.38%Maintains
a year ago
Exscientia PLCEXAI
4Hold$5.00+3.31%Downgrades
a year ago
Immunocore Holdings PLCIMCR
2Strong Buy$66.00+110.33%Maintains
a year ago
Blueprint Medicines CorpBPMC
9Hold$105.00-18.08%Maintains
a year ago
Nurix Therapeutics IncNRIX
2Strong Buy$31.00+172.17%Maintains
a year ago
Replimune Group IncREPL
3Strong Buy$17.00N/AMaintains
a year ago
Tango Therapeutics IncTNGX
1Strong Buy$13.00N/AMaintains
a year ago
Deciphera Pharmaceuticals IncDCPH
6Hold$26.00N/AUpgrades
a year ago
Immunogen IncIMGN
5Hold$31.00N/ADowngrades
2 years ago
Prelude Therapeutics IncPRLD
4Hold$5.00N/AMaintains
2 years ago
Neximmune IncNEXI
2Strong Buy$50.00N/AMaintains
3 years ago
Cytomx Therapeutics IncCTMX
3Strong Buy$3.50N/AMaintains
3 years ago
Illumina IncILMN
1Strong Sell$365.00N/AMaintains
4 years ago
Agios Pharmaceuticals IncAGIO
2Strong Buy$46.00N/AUpgrades
5 years ago
Immunomedics IncIMMU
1Strong Buy$40.00N/AInitiates Coverage On
5 years ago
Epizyme IncEPZM
1Strong Buy$33.00N/AInitiates Coverage On
5 years ago
Nektar TherapeuticsNKTR
1Strong Buy$450.00N/AInitiates Coverage On
5 years ago
Tesaro IncTSRO
1Hold$75.00N/ADowngrades
7 years ago
Celyad Oncology SaCYADY
1Strong Buy$49.00N/AInitiates Coverage On
7 years ago
Editas Medicine IncEDIT
1Strong Buy$45.00N/AUpgrades
7 years ago
Crispr Therapeutics AgCRSP
1Strong Buy$45.00N/AUpgrades
7 years ago
Juno Therapeutics IncJUNO
1HoldN/AN/ADowngrades
7 years ago
Affimed NvAFMDQ
1Strong Buy$70.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.